Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Kailera IPO'd in 2025 with HRS9531 (dual GLP-1/GIP, Phase 3 China readout ~17.7% weight loss February 2026) as its lead asset and HRS-4729 (the triple agonist) as an earlier-stage follow-on
Isotretinoin (generic for Accutane) treats severe nodular acne that is unresponsive to other treatments
The record is dispersed rather than uniform: BPC-157 has repeated recent purity failures, GHK-Cu shows fill overages, and some otherwise current, high-volume evidence lacks batch IDs
While it's essential to recognize that the FDA does not endorse off-label use, the demand for Ozempics weight loss magic couldn't be ignored, leading to practitioners across the country taking the obesity fight into their own handsor prescription pads
Thus, the rising geriatric population prone to diabetes across Asia Pacific would propel the demand for effective treatments such as GLP-1 analogues during the forecast period
US$ 29.50
US$ 25.98
US$ 20.59
US$ 20.28
US$ 29.87
